Douglas R. Lowy - Bethesda MD, US John T. Schiller - Silver Spring MD, US Heather Greenstone - Silver Spring MD, US
Assignee:
The United States of America, as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 39/12
US Classification:
4242041, 4241921, 435 6
Abstract:
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Douglas R. Lowy - Bethesda MD, US John T. Schiller - Silver Spring MD, US Heather Greenstone - Silver Spring MD, US
Assignee:
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services - Rockville MD
International Classification:
A61K 39/00
US Classification:
4241921
Abstract:
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
The present invention provides a papillomavirus-like particle having conformational epitopes comprising a papillomavirus L1 fusion product and, optionally, a papillomavirus L2 product; and related DNA molecules, host cells, and methods.
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Douglas Lowy - Bethesda MD, US John Schiller - Silver Spring MD, US Heather Greenstone - Silver Spring MD, US
International Classification:
C12N015/86 C12N007/00
US Classification:
435/235100, 435/456000
Abstract:
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Douglas Lowy - Bethesda MD, US John Schiller - Silver Spring MD, US Heather Greenstone - Silver Spring MD, US
International Classification:
A61K039/12 C12Q001/70 C12N007/00 C12N015/86
US Classification:
424204100, 435005000, 435235100, 435456000
Abstract:
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Douglas R. Lowy - Bethesda MD, US John T. Schiller - Silver Spring MD, US Heather Greenstone - Silver Spring MD, US
International Classification:
A61K 39/12 A61P 31/12
US Classification:
4242041
Abstract:
The present invention provides a papillomavirus-like particle, characterized as having conformational epitopes, comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; and related synthetic DNA molecules, host cells, methods and vaccines.
Douglas R. Lowy - Bethesda MD John T. Schiller - Silver Spring MD Heather Greenstone - Silver Spring MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 3900 A61K 3912 C12P 2106 C12N 700
US Classification:
4241921
Abstract:
The present invention provides a papillomavirus-like particle having conformational epitopes comprising a papillomavirus L1 fusion product and, optionally, a papillomavirus L2 product; and related DNA molecules, host cells, and methods.